NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Indian companies are ready to invest in pharmaceutical production in Belarus, Ambassador Extraordinary and Plenipotentiary of India to Belarus Manoj Kumar Bharti told reporters on 21 January, BelTA has learned.  India invites Belarusian companies to come to the Indian market and invest in various economic sectors. According to the diplomat,…

news

“We are hopeful that more sponsors of clinical trials, in general, will recognize the value of providing access to similar data,” Waldstreicher said. For now, it’s not clear if others will follow suit. Spokespersons from medical technology companies including Boston Scientific, Medtronic, St. Jude Medical, Abbott, and Edwards Lifesciences either…

news

Denmark based pharmaceutical firm Novo Nordisk today launched it's combination diabetic drug Ryzodeg, priced at Rs 1,595 for 300 units, for people with type II diabetes in India. Apart from India, Ryzodeg has been approved for marketing in Aruba, Brazil, Chile, Costa Rica, El Salvador, EU, Hong Kong, Iceland, Israel,…

news

Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today announced presentations on the Company's rapid, six-day manufacturing process for the production of Kite's lead product candidate, KTE-C19. The manufacturing technology enables a patient's T cells to…

news

Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for three-month atypical antipsychotic paliperidone palmitate to treat schizophrenia in adults. If approved, it will be the first and only long-acting atypical antipsychotic that…

news

BMG Pharma S.r.l. (BMG) today is pleased to announce that it has signed an exclusive distribution agreement with FERRER INTERNACIONAL S.A. (Ferrer), granting them the rights to promote, sell and market its own product GelX® for the Middle East, Eastern Europe, Russia and North Africa. The launch of GelX® will…

news

T-Bird Pharma Inc., a pharmaceutical company focused on developing premium quality medical marijuana products and a licensed producer ("LP") under the Marihuana for Medical Purposes Regulations (Canada) ("MMPR"), wishes to announce that Robert Gagnon has stepped down as CEO and Board member.  Dr. Bin Huang, who joined the Company last…

news

Solasia Pharma K.K. announced today that Solasia and Meiji Seika Pharma Co. Ltd., (Headquarters: Tokyo, Japan, President: Daikichiro Kobayashi, hereinafter “Meiji”) have entered into a license agreement for the development and commercialization of darinaparsin (intravenous formulation) in Japan. Solasia is currently completing a Phase I study of darinaparsin in Japan…

news

Supernus Pharmaceuticals, Inc. announced that it sued generic drug makers Par Pharmaceutical Companies, Inc. and Par Pharmaceutical, Inc. (collectively "Par") for infringement of four patents covering its antiepileptic drug Trokendi XR®. Supernus' United States Patents Nos. 8,298,576, 8,298,580, 8,663,683 and 8,877,248 cover once-a-day topiramate formulations and methods of treating seizures…

news

Alliance Pharma plc (APH.L), announced Monday that it expects fiscal year 2014 turnover to be 43.5 million pounds and pre-tax profits in line with the current market projections. In the prior year the company has reported 45.3 million pounds on IFRS basis, after restatement. According the company sales for Hydromol…